- Home
- SPCB vs ALGS Comparison
SPCB vs ALGS Comparison
Compare SPCB & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPCB | ALGS |
|---|---|---|
| Founded | 1988 | 2018 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.8M | 39.9M |
| IPO Year | 2004 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SPCB | ALGS |
|---|---|---|
| Price | $10.27 | $4.90 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $39.33 |
| AVG Volume (30 Days) | 76.9K | ★ 121.7K |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 88.30 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,186,000.00 |
| Revenue This Year | N/A | $32.20 |
| Revenue Next Year | $27.13 | $4.71 |
| P/E Ratio | $10.36 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.07 | $5.01 |
| 52 Week High | $13.57 | $13.69 |
Technical Indicators
Market Signals| Indicator | SPCB | ALGS |
|---|---|---|
| Relative Strength Index (RSI) | 45.73 | 34.64 |
| Support Level | $9.76 | N/A |
| Resistance Level | $10.86 | $6.82 |
| Average True Range (ATR) | 0.60 | 0.41 |
| MACD | -0.14 | -0.03 |
| Stochastic Oscillator | 5.37 | 7.63 |
Price Performance
Historical ComparisonAbout SPCB SuperCom Ltd. (Israel)
SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.